{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":27,"n_cols":5,"rows_kept":27,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[12,2,12,3],[13,2,13,3],[14,2,14,3],[15,2,15,3],[17,2,17,3],[18,2,18,3],[21,2,21,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910960557803321"]
[null,null,"Titolo",null,"Blood banking and regulation : procedures, problems, and alternatives / / Forum on Blood Safety and Blood Availability, Division of Health Sciences Policy, Institute of Medicine ; Edward A. Dauer, editor"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C., : National Academy Press, c1996"]
[null,null,"ISBN",null,"9786610191970"]
[{"$nulls":4},"9780309175326"]
[{"$nulls":4},"0309175321"]
[{"$nulls":4},"9781280191978"]
[{"$nulls":4},"128019197X"]
[{"$nulls":4},"9780309589505"]
[{"$nulls":4},"0309589509"]
[{"$nulls":4},"9780585155494"]
[{"$nulls":4},"0585155496"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (137 p.)"]
[null,null,"Disciplina",null,"362.1/784/0973"]
[null,null,"Soggetti",null,"Blood banks - Safety regulations - United States"]
[{"$nulls":4},"Blood - Transfusion - Safety regulations - United States"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"The talks summarized in this document were originally given at workshops on Alter[n]ative Regulatory Models (January, 1995); CBER Compliance Acivity, Theory and Practice (September, 1995); and Managing Threats to the Blood Supply (September, 1995)\"--P. vii."]
[null,null,"Nota di contenuto",null,"Blood Banking and Regulation: Procedures, Problems, and Alternatives -- Copyright -- Foreword -- Preface -- Contents -- I Overview of Regulatory and Policy-Making Procedures in Blood Banking -- FDA Policy and Regulation -- THE REGULATORY MANDATE -- REGULATORY MECHANISMS -- LEGAL AUTHORITIES -- REGULATION AND ENFORCEMENT AT FDA -- ENSURING BLOOD SAFETY AND AVAILABILITY IN THE FUTURE -- CDC Recommendations -- CDC'S MISSION -- EFFECTIVENESS OF CDC -- RESEARCH ON HIV -- HOW CDC AFFECTS POLICY -- FORMAL RECOMMENDATIONS -- Blood Banking's Policy Groups and Procedures -- THE TRADITION OF SELF-REGULATION -- STANDARD-SETTING ORGANIZATIONS -- AMERICAN ASSOCIATION OF BLOOD BANKS -- JOINT EFFORTS -- OTHER STANDARDS AND "]
[{"$nulls":4},"GUIDELINES -- Opportunities and Venues for Dialogue -- THE CHANGING CLIMATE IN BLOOD BANKING -- VENUES FOR DIALOGUE -- THE BLOOD PRODUCTS ADVISORY COMMITTEE -- OTHER VENUES FOR DIALOGUE -- THE VOICE OF BLOOD PRODUCT CONSUMERS -- ATTENDING TO THE DONOR -- REGULATORY DIFFICULTIES -- Discussion -- II Regulatory Enforcement And Compliance -- CBER Compliance Activity -- COORDINATION BETWEEN THE CENTERS AND THE FIELD -- OFFICE OF REGULATORY AFFAIRS -- INSPECTION CONSISTENCY -- INSPECTIONS AND ENFORCEMENT -- FDA Practice in the Field -- TRAINING FOR THE FIELD -- SOURCES OF CONSISTENCY -- Challenges and Questions About Compliance -- IMPROVEMENTS IN SAFETY -- QUESTIONS ABOUT ENFORCEMENT -- Evidence That Compliance Works -- Indirect Effects: \"Bulletproofing -- Is Compliance Improving? -- REGULATION AND OTHER FORCES -- Discussion -- III Innovations and Alternatives in Regulation -- Regulatory Alternatives -- REGULATORY DIAGNOSIS AND MISMATCH -- MAXIMIZING EFFECTIVENESS AND EFFICIENCY -- PROPOSED ALTERNATIVES TO COMMAND-AND-CONTROL -- Specific Techniques -- ACUS STUDY AND RECOMMENDATIONS -- THE ADMINISTRATIVE PROCEDURE ACT -- THE ALTERNATIVE: NEGOTIATION."]
[{"$nulls":4},"RECENT DEVELOPMENTS AND THE FEDERAL ADVISORY COMMITTEE ACT (FACA) -- AUDITED SELF-REGULATION -- Negotiated Rule-Making -- REG-NEG\"-DOES IT WORK? -- THE PUBLIC AT THE NEGOTIATION TABLE -- CONSENSUS -- DECISION-MAKING DYNAMICS -- BENEFITS OF COLLABORATION -- POLITICAL CONSENSUS -- REG-NEG OUTCOMES -- GETTING REG-NEG STARTED -- CHOOSING THE PROBLEM -- OTHER REQUISITES -- CONSTITUENCY PRESSURES -- ACCOUNTABILITY -- REG-NEG PROCESS -- QUESTIONS ABOUT REG-NEG -- Panel Discussion on Applications of Negotiated Rule-Making to Issues in Blood Banking -- Kathryn C. Zoon -- REGULATORY INITIATIVES AT FDA -- FDA IN THE FUTURE -- INITIATIVES AT CBER -- WILLINGNESS TO EXPLORE PILOTS -- Jay Epstein -- INITIATIVES IN BLOOD REGULATION -- PARTICIPATORY DECISION-MAKING -- PUBLIC MEETINGS -- NATIONAL PERFORMANCE REVIEW -- EXPERIMENTS IN REGULATION -- THE FORCES OF CHANGE -- THE ROLE OF THE RULE-MAKING PROCESS -- Toby Simon -- COMMENTS AND QUESTIONS -- General Discussion of Issues for Negotiated Rule-Making -- CRITERIA FOR SELECTING ISSUES -- CANDIDATES FOR REG-NEG -- IV Congressional Oversight and Regulatory Initiatives -- Congressional Oversight of Blood Safety Issues -- THE WORK OF THE SUBCOMMITTEE -- THE QUESTION OF COSTS -- DHHS Task Force on HIV and the Blood Supply -- THE TASK FORCE CHARGE -- BLOOD PRODUCTS ADVISORY COMMITTEE -- DECISION-MAKING -- COST AS A FACTOR -- THE PUBLIC VIEW -- V Postscript -- Investing in Regulatory Quality -- REQUISITES OF REGULATORY PROCEDURES -- PUBLIC PERCEPTIONS -- Appendixes -- A Negotiated Rule-Making Procedure -- Preamble --  561. Purpose --  562. Definitions --  563. Determination of need for negotiated rulemaking committee --  564. Publication of notice -- applications for membership on committees --  565. Establishment of committee --  566. Conduct of committee activity --  567. Termination of committee."]
[{"$nulls":4},"568. Services, facilities, and payment of committee member expenses --  569. Role of the Administrative Conference of the United States and other entities --  570. Judicial review -- B Workshop Participants -- WORKSHOP ON RISK AND REGULATION -- WORKSHOP ON MANAGING THREATS TO THE BLOOD SUPPLY -- C Acronyms."]
[null,null,null,"Sommario/riassunto","This volume examines regulatory and policymaking procedures in blood banking, regulatory enforcement and compliance, innovations and alternatives in regulation, congressional oversight and regulatory "]
[{"$nulls":4},"initiatives, and investment in regulatory quality."]